Status:
COMPLETED
Evaluation of the Effectiveness of Prophylactic LMWH by Thromboelastography
Lead Sponsor:
Ege University
Conditions:
Malignancy
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to evaluate the necessity and effectiveness of using low molecular weight heparin (LMWH) for prophylaxis in the postoperative period in patients who underwent lobectomy due to malignan...
Detailed Description
General characteristics of the patients such as age, gender, presence of comorbidities, smoking, type of operation and approach applied, operation duration, TEG measurements and postoperative complica...
Eligibility Criteria
Inclusion
- Patients who underwent lobectomy with thoracotomy or videothoracoscopy (VATS) due to malignancy (primary or secondary lung cancer)
Exclusion
- Patients with a known diagnosis of bleeding or coagulation disorders
- Patients receiving anticoagulant and antiplatelet therapy in the preoperative period
- Patients who developed perioperative bleeding and therefore underwent perioperative blood and blood product replacement
Key Trial Info
Start Date :
July 24 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 6 2025
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06484231
Start Date
July 24 2023
End Date
August 6 2025
Last Update
August 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ege University Faculty of Medicine
Izmir, Bornova, Turkey (Türkiye), 35100